|Day Low/High||2.32 / 2.66|
|52 Wk Low/High||2.32 / 49.80|
Presentation provides data on GALE-301/GALE-302 dosing and treatment schedules
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Galena Biopharma Inc , where a total volume of 54,709 contracts has been traded thus far today, a contract volume which is representative of approximately 5.5 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 161.5% of GALE's average daily trading volume over the past month, of 3.4 million shares.
Here's a technical look at how to trade some of the most active stocks on the market right now.
The inevitable failure of Galena Biopharma's breast cancer vaccine NeuVax was apparent in shoddy clinical data presented four years ago. On Wednesday, the bear call on Galena was proven correct.
Investors in Galena Biopharma Inc saw new options begin trading this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new August 19th contracts and identified one put and one call contract of particular interest.